As the ISMP LASA list or Confused Drug Name list has grown exponentially over the years and manufacturers are allowed to make identical looking products without repercussions how have healthcare systems responded?

Our hospital utilizes the chemo lock product for our chemo preparations. One issue we have run into are small volume chemo < 1ml. To affix a needle to the chemo syringe with a chemo lock the nurse is to affix a chemo port to the chemo lock. The problem is the lost volume of ~0.13-0.15 from the port. This lost volume can be substantial in low volume doses of chemo.

For hospitals that utilize chemo locks for their chemo preparations, what do you have your nurses do to affix the needle to the syringe?

Hi,

Our organization is in the process of standardizing our intravenous infusion pumps to the Baxter Novum IQ Large Volume Infusion pumps. Our EHR is Cerner.

We are looking to connect with other organizations who have undergone and/or are in the process of going to interoperability with Baxter/Cerner.

Please let me know if you would be interested in connecting offline.

Thanks!

Hello,

Curious to know if anyone has Lutetium Dotatate built in their smart infusion pump library or if you are running it as a basic infusion.

Thank you!
Maha Kebir, PharmD, MS, BCPS, CPHQ, CPPS

Admelog is not FDA approved for use in Tandem, Medtronic and Beta Bionic insulin pumps. Our formulary insulin lispro is Admelog.

If your organization allows patients to continue their insulin pumps while admitted, do you use Admelog insulin to refill the reservoir if the need arises?

Thanks,
Sloane Hoefer
Nebraska Medicine

I am seeking information on what is required for Independent Double Check for Vasopressors and Vasodilators at your facilities. We are updating our current IDC requirements and have suggestions for IDC to be required for initiation, bag change and handoff for Dopamine, Epinephrine, Isoproterenol, Phenylephrine and Vasopressin, Others have requested IDC initial, bag change, handoff only for Epinephrine and no IDC required for the other infusions.

For weight-based doses of Bicillin that are smaller than the prefilled syringe, are you drawing those up patient-specific or dispensing the full syringe with its original labelling?

The commercial product has a very strong statement that says, “WARNING: FATAL IF GIVEN BY OTHER ROUTES,” which you can see in the photo below. If transferring the patient’s dose to a standard IV syringe for IM administration, we would lose this labeling and increase the risk of inadvertent IV administration.

Hello colleagues,

How do you dispense Lugol's solution when dosed in drops for ORAL use (i.e. thyroid storm)? Do you convert to mL and draw up doses, dispense bottles with droppers? Looking to assure safe dispensing around this rarely used drug.

Thank you,

Megan Fragale, PharmD, MS, BCPS
Medication Safety Officer
Skagit Regional Health

Good morning -
I am looking for input from facilities currently using a low-pressure manifold with a syringe pump (ideally Alaris). We are aware of the FDA alert specifically advising against use of high-pressure manifolds with Alaris, but the ICU Medical manifold appears not to apply in this case. We are evaluating using the ICU Medical manifold with the Alaris syringe module and would love feedback from sites that currently use this setup with success. Have you had any issues with cracking or inadvertent bolusing?

Hello!
I have a question specific to adverse reaction reporting...While reviewing our ADR report, a question came up about reactions reported as elevated INR, or other increased levels. Unlike hyperkalemia, some of these do not have an ICD 10 code as a condition. Another example might be elevated CPK but not associated with rhabdomyolysis or other symptoms.

Do you include elevated levels in your reaction reporting? Specifically, if there is not a clinical symptom associated with it?